Analysts have said the companies will likely split the U.S. market roughly 50-50 by the end of 2024, as Lilly bolsters its manufacturing capacity and closes the gap with Novo
| Subscribe To Our Free Newsletter |
The Most Valuable Commodity Is Information!
